Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.
about
Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural proteinCoronavirus virulence genes with main focus on SARS-CoV envelope geneCharacterization of an Immunodominant Epitope in the Endodomain of the Coronavirus Membrane ProteinStructure and inhibition of the SARS coronavirus envelope protein ion channelVirus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenzaImmunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pigEffect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in miceVirus like particle-based vaccines against emerging infectious disease viruses.Structure of a conserved Golgi complex-targeting signal in coronavirus envelope proteinsChimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles.Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine.A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike proteinSubviral particle as vaccine and vaccine platform.Self-assembly and release of peste des petits ruminants virus-like particles in an insect cell-baculovirus system and their immunogenicity in mice and goats.A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein.Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice.Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells.Baculovirus as versatile vectors for protein expression in insect and mammalian cells.A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo.The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein.Exceptional flexibility in the sequence requirements for coronavirus small envelope protein functionBaculovirus as a highly efficient expression vector in insect and mammalian cells.Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoVHosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.Identifying SARS-CoV membrane protein amino acid residues linked to virus-like particle assembly.SARS coronavirus accessory proteins.MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Virus-like particles in vaccine development.Insect cells as a production platform of complex virus-like particles.The application of virus-like particles as vaccines and biological vehicles.Recent advancements in combination subunit vaccine development.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells.Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design.Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M.Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein.Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein forms a dimer through its C-terminal domain.
P2860
Q24674321-1AE87E4E-16BA-4149-874B-92C668E21E16Q26827561-595E1EF4-7F52-477A-B45F-33E1BC1FE26CQ28354737-B0FC38C1-549C-4D9E-8E8D-D6D436593A33Q28475712-6A77CFF0-88A1-4654-8E4A-9B0972A0FA08Q28741801-2F30C523-0D44-4C61-8A1E-B206AE491B70Q28743371-B2596918-6813-4709-B38B-2CE4EB3B1A50Q28751866-5E689BC6-A734-41B3-8DE6-770D584AFDD5Q30249025-853B537A-D85C-4D42-BBA8-E3C30D7A66DDQ30360640-8854908C-FFB7-44C7-A564-03A04B58DE57Q30404941-45B67574-CA02-47B5-B85E-EBE8DCFDDF34Q30484261-A3397657-249D-4575-BC95-0068E39BC597Q33338439-E5CC7A63-0CD6-4E4D-B143-A049BC780CFAQ33614610-CC082755-A6BB-49F6-8D72-44F5545870A7Q33812653-B0B65210-5856-4794-BA46-FC3ECF074A2AQ34035499-A6053AF0-9DAD-4E1D-91E1-A748320104E5Q34092794-F50452C1-B92E-4A7D-A972-FDB671FE7FF1Q34142905-5D0555F8-2234-4429-A964-361EE0706AEDQ34233067-85CCDF24-6B03-420C-BD81-6916A4A9EEA7Q34416430-64365F17-B66E-4F50-8C53-1F9C3A1D0041Q35635337-47CFBF60-4810-4B87-A0CF-7E58A058CE3FQ35784645-2B14736A-0BC9-4EBA-ABFF-DB6B1804B1E9Q35784722-A82F1B68-F652-4C1A-A21D-FC44B00BAA6BQ36075878-2EB1E40B-2287-4092-AA1F-97D7C39EC482Q36496355-4573BAF7-3143-4735-B79F-BABD1974C862Q36520754-729D5941-82C8-4BA7-8FAE-FEBAD1A9A727Q36784740-04BE2BEF-01FC-4D32-ADE2-071D6F96166DQ36859360-EBAEA0E6-9652-4747-A630-1AA9CC6FBF49Q37018286-1C9F46F6-AF1A-4990-911F-9F0C9946E8A7Q37706472-D20E5BF0-C966-4F7B-9878-0CE04903EF95Q37792984-FE4A280A-38EA-478F-885B-43E19E39551DQ37798008-1653C5FD-CD36-415C-AF57-0E496B984ED8Q38081976-76FC1FBE-9160-4927-94B2-B4866291B674Q38603912-2CDB9073-E77F-44C9-8480-0853B9B43E00Q38819439-2B01395D-97A1-40F7-9B68-87427FFE007AQ39102732-DD64B9C1-21D7-4325-856F-62C14288C308Q40347096-A138F381-FE57-48B8-81A9-FC7C4A85AEF5Q41209873-2CAF020E-8525-4949-BDCF-C998E580060CQ41861879-55AE1047-CF2C-4DC0-8135-F52BCE2AC56DQ42036937-A4B3F1B8-4A0D-449B-8C93-B68E6D2ED464Q47809133-9ECD672D-9FCC-44C4-B827-88FA47DFF139
P2860
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Efficient assembly and release ...... eterologous expression system.
@en
Efficient assembly and release ...... eterologous expression system.
@nl
type
label
Efficient assembly and release ...... eterologous expression system.
@en
Efficient assembly and release ...... eterologous expression system.
@nl
prefLabel
Efficient assembly and release ...... eterologous expression system.
@en
Efficient assembly and release ...... eterologous expression system.
@nl
P2860
P1433
P1476
Efficient assembly and release ...... heterologous expression system
@en
P2093
Eduardo Mortola
P2860
P304
P356
10.1016/J.FEBSLET.2004.09.009
P407
P50
P577
2004-10-01T00:00:00Z